Prekeris, R., M.W. Mayhew, B.J. Cooper, and D.M. Terrian. 1996. Identification and localization of an actin-binding motif that is unique to the epsilon isoform of protein kinase C and participates in the regulation of synaptic function. J. Cell Biol. 132: 77-90.
Prekeris, R. and D.M. Terrian. 1997. Brain myosin V is a synaptic vesicle-associated motor protein: evidence for a Ca2+-dependent interaction with the synaptobrevin-synaptophysin complex. J. Cell Biol. 137: 1589-1601.
Prekeris, R., R.M. Hernandez, M.W. Mayhew, M.K. White, and D.M. Terrian. 1998. Molecular analysis of the interactions between protein kinase C-ε and filamentous actin. J. Biol. Chem. 273: 26790-26798.
Wu, D., T.L. Foreman, C.W. Gregory, M.A. McJilton, G.G. Wescott, O.H. Ford, R.F. Alvey, J.L. Mohler, and D.M. Terrian. 2002. Protein kinase C-epsilon has the potential to advance the recurrence of human prostate cancer. Cancer Res. 62: 2423-2429.
Wu, D. and D.M. Terrian. 2002. Regulation of caveolin-1 expression and secretion by a protein kinase C-epsilon signaling pathway in human prostate cancer cells. J. Biol. Chem. 277: 40449-40455.
Terrian, D.M. (Ed.). 2003. Cancer Cell Signaling: Methods and Protocols. Methods in Molecular Biology. Humana Press, Totowa, New Jersey. 218:1-333.
McJilton, M.A., C.V. Sikes, G.G. Wescott, D. Wu, T.L. Foreman, C.W. Gregory, D.A. Weidner, O.H. Ford, A.M. Lasater, J.L. Mohler, and D.M. Terrian. 2003. Protein kinase Cε interacts with Bax and promotes survival of human prostate cancer cells. Oncogene. 22:7958-7968.
Wu, D., C.U. Thakore, G.G. Wescott, J.A. McCubrey, and D.M. Terrian. 2004. Integrin signaling links protein kinase C-epsilon to the protein kinase B/Akt survival pathway in recurrent prostate cancer cells. Oncogene 23: 8659-8672.
Lehmann, B.D., J.A. McCubrey, M.S. Paine, W.H. Chappell, and D.M. Terrian. 2007. A dominant role for p53-dependent cellular senescence in radiosensitization of human prostate cancer cells. Cell Cycle 6: 595-605.
Thakore, C.T., B.D. Lehmann, J.A. McCubrey, and D.M. Terrian. 2007. Intracellular signaling in cancer. Cancer: From Mechanisms to Therapeutic Approaches (R.A. Meyers, ed.). Wiley-VCH Verlag GmbH, Weinheim. 155-190.
Lehmann, B.D., J.A. McCubrey, and D.M. Terrian. 2007. Radiosensitization of prostate cancer by priming the wild-type p53-dependent cellular senescence pathway. Cancer Biol. Ther. 6: 1165-1170.
Steelman, L.S., P.M. Navolanic, M.L. Sokolosky, J.R. Taylor, B.D. Lehmann, W.H. Chappell, S.L. Abrams, E.W.T. Wong, K.M. Stadelman, D.M. Terrian, N.R. Leslie, C.P Downes, A.M. Martelli, F. Stivala, M. Libra, R.A. Franklin, and J.A. McCubrey. 2008. Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibition. Oncogene 27: 4086-4095.
Lehmann, B.D., M.S. Paine, A.M. Brooks, W.H. Chappell, J.A. McCubrey, and D.M. Terrian. 2008. Distinct roles for p107 and p130 in Rb-independent cellular senescence. Cell Cycle 7: 1262-1268.
Lehmann, B.D., M.S. Paine, A.M. Brooks, J.A. McCubrey, R.H. Renegar, and D.M. Terrian. 2008. Senescence-associated exosome release from human prostate cancer cells. Cancer Res. 68: 7864-7871.
View PubMed Publications for further listings